Please login to the form below

Not currently logged in
Email:
Password:

pharma pricing

This page shows the latest pharma pricing news and features for those working in and with pharma, biotech and healthcare.

It’s only money

It’s only money

Smart Thinking blog. Insights and expert advice on the key issues facing today’ s pharma marketer. ... It’ s only money. Pricing and penalties. Apple is slowing down iPhones.

Latest news

  • Gilead makes $11.9bn play for CAR-T specialist Kite Gilead makes $11.9bn play for CAR-T specialist Kite

    Investors have been clamouring for Gilead Sciences to make a big acquisition to bulk up its pipeline, and the company delivered with a $11.9bn deal to buy Kite Pharma, specialising ... will reach the market at a time when scrutiny of pharma pricing is

  • Warning sounded on pharma's long-term sales prospects Warning sounded on pharma's long-term sales prospects

    Warning sounded on pharma's long-term sales prospects. Analysts at EvaluatePharma downgrade their projections in face of pricing pressures and biosimilar competition. ... For the first time in a decade, EvaluatePharma has amended its long-term sales

  • Biogen wins European spinal muscular atrophy first Biogen wins European spinal muscular atrophy first

    The wince-inducing price tag led some analysts to suggest Biogen could be dragged into the ongoing debate about the sustainability of pharma pricing in the US, with Leerink saying at ... To that end it recently bought late-stage stroke candidate Cirara

  • EU starts investigation of Aspen's cancer drug pricing EU starts investigation of Aspen's cancer drug pricing

    The European Commission said it was looking into concerns that the South African pharma company had "engaged in excessive pricing" for the five drugs - with reports that some drugs had their ... possible price-fixing among generic medicine drugs in the

  • Focus on value: A prescription for pharma Focus on value: A prescription for pharma

    Focus on value: A prescription for pharma. The pricing debate demands a common language to be developed. ... Pricing of pharmaceutical products has been at the centre of the debate on how to contain the rapid rise in healthcare costs for several years.

More from news
Approximately 3 fully matching, plus 70 partially matching documents found.

Latest Intelligence

  • 2016: The year when deal-makers took stock? 2016: The year when deal-makers took stock?

    Fewer NCEs coming through. Politics and pricing certainly had an impact, with the US backlash against aggressive pharma pricing following Mylan's EpiPen debacle, itself coming on the heels of the ... Digital health is expected to be a major investment

  • Taking a strategic approach Taking a strategic approach

    Earlier this year a WHO report released attacked pharma's 'opaque' policy on drug pricing and said the industry must be more transparent. ... A survey of patient groups by PatientView found patients too think pharma often falls short when it comes to

  • Turkey: A growing pharma market with huge potential Turkey: A growing pharma market with huge potential

    While the Turkish government tries to balance increasing public health spending with a rigid pharma pricing policy for pharmaceuticals, in 2012 pharmaceutical spending in Turkey accounted for 1.02 % of GDP. ... The pharma pricing remains one of the most

  • India has big plans for healthcare and pharma India has big plans for healthcare and pharma

    Pharma is likely to explore tiered pricing systems to fit in with India's vast spectrum of poverty and wealth, she adds. ... There is a lot of potential but pharma will need flexible strategies,” adds Krishnan. “

  • The evolution of IQWiG in Germany’s drug pricing policy The evolution of IQWiG in Germany’s drug pricing policy

    But just one year later in 2011, prompted by pricing pressures from pharma and a stalling European economy, Germany enacted the “ Law on the Reorganisation of the Pharmaceutical Market” (AMNOG), which ... Guhl says: “ The communication between

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest from PMHub

  • Pricing's Point Man

    Pricing's Point Man. In the wake of the publication of the second edition of 'The Price of Global Health', Ed Schoonveld talks to William Looney. ... this relatively new set of pharma capabilities to the next level— from theory to practice.

  • A roadmap to strategic drug pricing

    A roadmap to strategic drug pricing. The current unit-based pricing model for drugs is too one-dimensional for the market's present needs. ... Pharma firms must identify products that will benefit from innovative pricing models, and then forge the types

  • Free Thinking - US Presidential Election: The legacy of the Affordable Care Act and the future for healthcare

    November, we ask, what is the likely impact of a Republican or Democrat win on the future of the ACA, the health system and the pharma industry? ... The effect on pharma. - The need to demonstrate real long-term value.

  • C.E.L.forpharma

    C.E.L.forpharma. C.E.L.forpharma stands for “ Centre for Executive Leadership for the pharmaceutical industry” and offers pharma executives the opportunity to be trained face-to-face by ... internationally acclaimed experts in 2-day public courses on

  • Training

    C.E.L.forpharma stands for “ Centre for Executive Leadership for the pharmaceutical industry” and offers pharma executives the opportunity to be trained face-to-face by internationally acclaimed experts in ... 2-day public courses on • Pharma Sales

More from PMHub
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics